1. World Health Organization. Global tuberculosis report: exclusive summary [Internet]. Geneva: World Health Organization;2018. [cited 2019 Mar 21]. Available from:. https://www.who.int/tb/publications/global_report/tb18_ExecSum_web_4Oct18.pdf.
2. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012; 367:348–61.
Article
3. World Health Organization. Roadmap for childhood tuberculosis: towards zero deaths [Internet]. Geneva: World Health Organization;2013. [cited 2019 Mar 21]. Available from:. https://apps.who.int/iris/bitstream/han-dle/10665/89506/9789241506137_eng.pdf.
4. Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health. 2018; 40:e2018036.
Article
5. Stop TB Partnership; World Health Organization. An international roadmap for tuberculosis research: towards a world free of tuberculosis [Internet]. Geneva: World Health Organization;2011. [cited 2019 Mar 21]. Available from:. http://www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf.
6. Kang PS, Lee SK. A study on the effects of BCG vaccination against tuberculosis. Korean J Prev Med. 1982; 15:33–46.
7. Lee H, Cho SN, Kim HJ, Anh YM, Choi JE, Kim CH, et al. Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea. Vaccine. 2011; 29:6564–71.
Article
8. Lee H, Dockrell HM, Kim DR, Floyd S, Oh SY, Lee JB, et al. The current status of BCG vaccination in young children in South Korea. Tuberc Respir Dis (Seoul). 2012; 72:374–80.
Article
9. Schrager LK, Harris RC, Vekemans J. Research and development of new tuberculosis vaccines: a review. F1000Res. 2018; 7:1732.
Article
10. Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, et al. Safety and immunogenicity of the recombinant
Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa. Clin Vaccine Immunol. 2017; 24:e00439–16.
Article
11. Scott KM, Lee HK, Ham SS, Park SO, Kim HD, Koh WH, et al. A study of household contacts of cases with pulmonary tuberculosis. Yonsei Med J. 1962; 3:74–8. CROSSREF.
Article
12. Medical Research Council Working Party. A controlled trial of plaster-of-paris jackets in the management of ambulant outpatient treatment of tuberculosis of the spine in children on standard chemotherapy. A study in Pusan, Korea. Second report of the Medical Research Council Working Party on Tuberculosis of the Spine. Tubercle. 1973; 54:261–82.
13. Oh HJ, Yoon HS, Bynn HS, Huh KY, Sohn C. Effects of rifampin (RMP) on liver function in tuberculous children. J Korean Pediatr Soc. 1981; 24:430–6.
14. Lee KS, Park KC, Shin MJ, Kang SC. Rifampin effects on tuberculous meningitis in children. J Korean Pediatr Soc. 1978; 21:543–51.
15. Stop TB Department; Department of Child and Adolescent Health and Development of the World Health Organization. A research agenda for childhood tuberculosis [Internet]. Geneva: World Health Organization;2007. [cited 2019 Mar 22]. Available from:. https://apps.who.int/iris/bitstream/handle/10665/69611/WHO_HTM_TB_2007.381_eng.pdf.
16. Child & Adolescent TB Working Group. Research priorities for paediatric tuberculosis [Internet]. New York, NY: Treatment Action Group;2018. [cited 2019 Mar 22]. Available from:. https://www.finddx.org/wp-content/uploads/2018/09/Paediatric_TB_ResearchPriorities_FINAL_Web.pdf.
17. Bekker A, Schaaf HS, Draper HR, van der Laan L, Murray S, Wiesner L, et al. Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines. Antimicrob Agents Chemother. 2016; 60:2171–9.
Article
18. Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, et al. Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2018; 62:e01521–17.
Article
19. McIlleron H, Hundt H, Smythe W, Bekker A, Winckler J, van der Laan L, et al. Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes. Int J Tuberc Lung Dis. 2016; 20:915–9.
Article
20. Garcia-Prats AJ, Draper HR, Finlayson H, Winckler J, Burger A, Fourie B, et al. Clinical and cardiac safety of longterm levofloxacin in children treated for multidrug-resistant tuberculosis. Clin Infect Dis. 2018; 67:1777–80.
Article
22. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010; 50(Suppl 3):S184–94.
Article
23. Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis. 2012; 55:1088–95.
Article
24. Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, et al. Performance of Xpert MTB/RIF and alternative specimen collection methods for the diagnosis of tuberculosis in HIV-infected children. Clin Infect Dis. 2016; 62:1161–8.
Article
25. Walters E, van der Zalm MM, Palmer M, Bosch C, Demers AM, Draper H, et al. Xpert MTB/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease. Pediatr Infect Dis J. 2017; 36:837–43.
Article
26. LaCourse SM, Cranmer LM, Njuguna IN, Gatimu J, Stern J, Maleche-Obimbo E, et al. Urine tuberculosis lipoarabinomannan predicts mortality in hospitalized human immunodeficiency virus-infected children. Clin Infect Dis. 2018; 66:1798–801.
Article
27. Portevin D, Moukambi F, Clowes P, Bauer A, Chachage M, Ntinginya NE, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis. 2014; 14:931–8.
Article
28. Sweeney TE, Braviak L, Tato CM, Khatri P. Genomewide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med. 2016; 4:213–24.
Article
29. Huh S. Recent advances of medical journals in Korea and and further development strategies: is it possible for them to publish Nobel Prize-winning research? J Korean Med Assoc. 2018; 61:524–31. CROSSREF.
Article
30. Nafade V, Nash M, Huddart S, Pande T, Gebreselassie N, Lienhardt C, et al. A bibliometric analysis of tuberculosis research, 2007–2016. PLoS One. 2018; 13:e0199706.
Article